Pluxee: plunge despite higher growth target
Details suggest a publication slightly below consensus expectations", points out UBS, which sees only limited short-term catalysts, and considers the stock to be fairly valued at current levels.
With sales up 14% to 297 million euros, third-quarter sales came in 2% below consensus, according to Oddo BHF, which nevertheless noted slightly better-than-expected organic growth of 17.9%.
While appreciating 'its profile of robust growth and operational improvement over the next few years, as well as the optionality on M&A', the research department considers that 'the current valuation implies only a limited discount to its main peers'.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction